Clinical Trials Browser

Phase 1/2 × Preleukemia × Alemtuzumab × Clear all

NCT00943592 2014-02-27

Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

Phase 1/2 Completed

82 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Preleukemia